Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis diagnostic criteria: three years later.

Chris H Polman1, Jerry S Wolinsky, Stephen C Reingold

  • 1Department of Neurology, VU Medical Centre, Amsterdam, The Netherlands. ch.polman@vumc.nl

Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 1, 2005
PubMed
Summary

The 2001 McDonald criteria for multiple sclerosis (MS) diagnosis, incorporating MRI, have been widely studied. This review evaluates key studies on the McDonald criteria

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.

Lancet (London, England)·2026
Same author

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.

Annals of neurology·2025
Same author

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same author

Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis.

Annals of clinical and translational neurology·2025
Same author

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

The Lancet. Neurology·2024
Same author

Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.

Scientific reports·2024

Area of Science:

  • Neurology
  • Diagnostic Imaging

Background:

  • The 2001 International Panel established new diagnostic criteria for multiple sclerosis (MS).
  • These criteria were the first to formally include magnetic resonance imaging (MRI) in the diagnostic process for suspected MS cases.
  • The McDonald criteria have undergone extensive study for their diagnostic accuracy and clinical utility.

Purpose of the Study:

  • To review and assess significant studies evaluating the McDonald criteria since their 2001 publication.
  • To prepare for a future re-evaluation of the McDonald criteria using accumulated data.

Main Methods:

  • Systematic review of retrospective and prospective studies.
  • Analysis of diagnostic performance metrics (sensitivity, specificity, utility) of the McDonald criteria.

Related Experiment Videos

  • Evaluation of studies comparing McDonald criteria against previous diagnostic standards.

    • Main Results:

    • The McDonald criteria have demonstrated favorable sensitivity and specificity in diagnosing MS.
    • Studies indicate the McDonald criteria are an improvement over earlier diagnostic methods for MS.
    • The criteria have shown significant utility in both retrospective and prospective patient cohorts.

    Conclusions:

    • The McDonald criteria represent a significant advancement in the diagnosis of multiple sclerosis.
    • Continued data collection and analysis are crucial for the ongoing refinement and validation of these diagnostic standards.
    • This review provides a foundation for the upcoming re-evaluation of the McDonald criteria.